Alzheimer's disease is a multifactorial pathology, for which no cure is currently available. Nowadays, researchers are moving towards a new hypothesis of the onset of the illness, linking it to a metabolic impairment. This innovative approach will lead to the identification of new targets for the preparation of new effective drugs. Peroxisome proliferator-activated receptors and their ligands are the ideal candidates to reach the necessary breakthrough to defeat this complicate disease.
Keywords: Alzheimer's disease; innovative therapies; metabolism; multifunctional drugs; neuroinflammation; peroxisome proliferator-activated receptors; type 2 diabetes mellitus; type 3 diabetes.